Ultimately the results will help the field of cancer research to learn how to combine and develop different therapies to achieve better clinical outcomes for
leukaemia patients.
By combining new systems biological analyses and advanced data analysis, a recent study led by Petter Brodin (Karolinska Institutet / SciLifeLab) have been able to monitor the maturation process of the immune system in
leukaemia patients who have undergone stem cell transplantation.
Not exact matches
Scientists at The Institute of Cancer Research, London, and the Wellcome Trust Sanger Institute used DNA sequencing to identify a panel of mutations present across thousands of cancer cells in three
patients with
leukaemia.
«This opens up bone - marrow transplants to virtually any
patient out there with a haematological condition» such as
leukaemia or sickle - cell anaemia, says John Tisdale, a haematologist at the US National Heart, Lung and Blood Institute in Bethesda, Maryland.
Leukaemia Foundation Queensland CEO Bill Petch said the test could help
patients access newer drugs in the future.
A trial of a gene treatment for children with severe combined immunodeficiency, who have no functioning immune system, was called off after some of the
patients developed
leukaemia.
The international research team, led by scientists at the University of Oxford and the Karolinska Institutet in Sweden, studied a group of
patients with myelodysplastic syndromes — a malignant blood condition which frequently develops into acute myeloid
leukaemia.
But in subsequent trials, four young
patients were diagnosed with
leukaemia two years after receiving a similar treatment.
A «miracle» gene therapy treatment for children suffering from the fatal «bubble boy» disease has been halted in France, after one of the
patients developed
leukaemia as a direct consequence of the treatment.
BAFF Levels Are Elevated in Paediatric
Patients With Acute Lymphoblastic
Leukaemia Compared to Other B - Lineage Neoplasms
Bornhäuser M, Kienast J, Trenschel R, et al Reduced - intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in
patients with acute myeloid
leukaemia in first complete remission: a prospective, open - label randomised phase 3 trial.
«The T cell
leukaemia seen in one of the
patients treated with gene therapy for SCID - X1 is extremely regrettable and our sympathies are with the child and his family as he undergoes chemotherapy.
Demonstrating not only their killing ability but also their potential as a therapy to treat
patients suffering from
Leukaemia.
Detection of a retrovirus, xenotropic murine
leukaemia virus - related virus (XMRV), has recently been reported in 67 % of
patients with chronic fatigue syndrome.
However, subsequent studies carried out on small numbers (20 — 30) of CFS
patients, failed to confirm evidence for HTLV (type 1 or 11)[22]--[25] or other retroviruses, including the closely - related simian T lymphotropic virus type l, the prototype foamy virus, simian retrovirus, bovine and feline
leukaemia viruses [26] and HIV - 1 [23].
At the Wellcome Trust Sanger Institute and the University of Cambridge, Dr George Vassiliou is looking to improve the survival of
patients with acute myeloid
leukaemia (AML).
Kidderminster, Worcs, UK About Blog Representing the needs of Chronic Myeloid
Leukaemia (CML)
patients globally.
Are survival and mortality rates associated with recruitment to clinical trials in teenage and young adult
patients with acute lymphoblastic
leukaemia?
Kidderminster, Worcs, UK About Blog Representing the needs of Chronic Myeloid
Leukaemia (CML)
patients globally.